Cancer stemness in hepatocellular carcinoma: mechanisms and translational potential (Q90776672)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32231294 AND SRC:MED&resulttype=core&format=json

16 April 2020

review article

1 reference

title

Cancer stemness in hepatocellular carcinoma: mechanisms and translational potential (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32231294 AND SRC:MED&resulttype=core&format=json

16 April 2020

main subject

hepatocellular carcinoma

1 reference

Yu-Man Tsui

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32231294 AND SRC:MED&resulttype=core&format=json

16 April 2020

Lo-Kong Chan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32231294 AND SRC:MED&resulttype=core&format=json

16 April 2020

Irene Oi-Lin Ng

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32231294 AND SRC:MED&resulttype=core&format=json

16 April 2020

publication date

31 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32231294 AND SRC:MED&resulttype=core&format=json

British Journal of Cancer

16 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32231294 AND SRC:MED&resulttype=core&format=json

The plastic cellular states of liver cells: Are EpCAM and Lgr5 fit for purpose?

16 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Cancer stem cells: A contentious hypothesis now moving forward.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Evolution of the cancer stem cell model

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Concise review: The Sox2-Oct4 connection: critical players in a much larger interdependent network integrated at multiple levels

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

CD24 Liver Tumor-Initiating Cells Drive Self-Renewal and Tumor Initiation through STAT3-Mediated NANOG Regulation

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Cancer stem cells: the challenges ahead

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Identification and characterization of tumorigenic liver cancer stem/progenitor cells

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

CD133 HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

CD13 is a therapeutic target in human liver cancer stem cells

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Identification of a unique hepatocellular carcinoma line, Li-7, with CD13( ) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

iNOS promotes CD24CD133 liver cancer stem cell phenotype through a TACE/ADAM17-dependent Notch signaling pathway

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Induction of tumor initiation is dependent on CD44s in c-Met⁺ hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

MELK is an oncogenic kinase essential for early hepatocellular carcinoma recurrence

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

TLR4 increases the stemness and is highly expressed in relapsed human hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Discrete nature of EpCAM and CD90 cancer stem cells in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

IRAK1 augments cancer stemness and drug resistance via the AP-1/AKR1B10 signaling cascade in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Blockade of CD47-mediated cathepsin S/protease-activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

In vitro expansion of single Lgr5 liver stem cells induced by Wnt-driven regeneration.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Leucine-rich repeat-containing G protein-coupled receptor 5 regulates epithelial cell phenotype and survival of hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5( ) liver cancer initiating cells by suppressing negative regulators of β-catenin signaling.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Dishevelled-3 phosphorylation is governed by HIPK2/PP1Cα/ITCH axis and the non-phosphorylated form promotes cancer stemness via LGR5 in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Overexpression of orphan G-protein-coupled receptor, Gpr49, in human hepatocellular carcinomas with beta-catenin mutations

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Insulin receptor isoform A favors tumor progression in human hepatocellular carcinoma by increasing stem/progenitor cell features

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition by way of Akt/GSK-3β/Snail signaling.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

TSC1/2 mutations define a molecular subset of HCC with aggressive behaviour and treatment implication

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

MYC activates stem-like cell potential in hepatocarcinoma by a p53-dependent mechanism.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Mitophagy Controls the Activities of Tumor Suppressor p53 to Regulate Hepatic Cancer Stem Cells

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Oncogenic STRAP Supports Hepatocellular Carcinoma Growth by Enhancing Wnt/β-Catenin Signaling

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

RBMY, a novel inhibitor of glycogen synthase kinase 3β, increases tumor stemness and predicts poor prognosis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

EpCAM-regulated intramembrane proteolysis induces a cancer stem cell-like gene signature in hepatitis B virus-infected hepatocytes

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Histone deacetylase 3 participates in self-renewal of liver cancer stem cells through histone modification

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

miR-130b Promotes CD133( ) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Octamer 4/microRNA-1246 signaling axis drives Wnt/β-catenin activation in liver cancer stem cells.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

lnc-β-Catm elicits EZH2-dependent β-catenin stabilization and sustains liver CSC self-renewal

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

The long non-coding RNA LncHDAC2 drives the self-renewal of liver cancer stem cells via activation of Hedgehog signaling

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

CD24 promotes HCC progression via triggering Notch-related EMT and modulation of tumor microenvironment

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell-like Behaviors Contributing to Disease Progression

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

ASPP2 suppresses stem cell-like characteristics and chemoresistance by inhibiting the Src/FAK/Snail axis in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

c-Met Signaling Is Essential for Mouse Adult Liver Progenitor Cells Expansion After Transforming Growth Factor-β-Induced Epithelial-Mesenchymal Transition and Regulates Cell Phenotypic Switch.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Transforming growth factor-beta and hepatocyte transdifferentiation in liver fibrogenesis

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

The two faces of transforming growth factor beta in carcinogenesis

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Hepatocellular Carcinomas Originate Predominantly from Hepatocytes and Benign Lesions from Hepatic Progenitor Cells

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Sirtuin-1/Mitochondrial Ribosomal Protein S5 Axis Enhances the Metabolic Flexibility of Liver Cancer Stem Cells

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Collagen 1A1 (COL1A1) Is a Reliable Biomarker and Putative Therapeutic Target for Hepatocellular Carcinogenesis and Metastasis

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell niche.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Hypoxia promotes vasculogenic mimicry formation by the Twist1-Bmi1 connection in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Lipopolysaccharide supports maintaining the stemness of CD133( ) hepatoma cells through activation of the NF-κB/HIF-1α pathway

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Annexin A3 as a potential target for immunotherapy of liver cancer stem-like cells

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Cancer-associated fibroblasts promote the stemness of CD24 liver cells via paracrine signaling

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Cancer-associated fibroblasts endow stem-like qualities to liver cancer cells by modulating autophagy

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Peri-tumor associated fibroblasts promote intrahepatic metastasis of hepatocellular carcinoma by recruiting cancer stem cells

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

TNF-α derived from M2 tumor-associated macrophages promotes epithelial-mesenchymal transition and cancer stemness through the Wnt/β-catenin pathway in SMMC-7721 hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

CXCL11 promotes self-renewal and tumorigenicity of α2δ1 liver tumor-initiating cells through CXCR3/ERK1/2 signaling

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Granulin-epithelin precursor and ATP-dependent binding cassette (ABC)B5 regulate liver cancer cell chemoresistance

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Oncogene-specific formation of chemoresistant murine hepatic cancer stem cells

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Interleukin-8 is related to poor chemotherapeutic response and tumourigenicity in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Knockdown of NANOG enhances chemosensitivity of liver cancer cells to doxorubicin by reducing MDR1 expression

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

NRBP2 Overexpression Increases the Chemosensitivity of Hepatocellular Carcinoma Cells via Akt Signaling

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Hepatic stellate cells secreted hepatocyte growth factor contributes to the chemoresistance of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Nuclear factor kappa B-mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

ANXA3/JNK Signaling Promotes Self-Renewal and Tumor Growth, and Its Blockade Provides a Therapeutic Target for Hepatocellular Carcinoma.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Genome-Wide RNAi Screen Identifies PMPCB as a Therapeutic Vulnerability in EpCAM Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Defeating EpCAM( ) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Stearoyl-CoA desaturase regulates sorafenib resistance via modulation of ER stress-induced differentiation.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

CD133( ) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

BMP4 administration induces differentiation of CD133 hepatic cancer stem cells, blocking their contributions to hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Baicalein targets GTPase-mediated autophagy to eliminate liver tumor initiating stem cell-like cells resistant to mTORC1 inhibition.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Transcriptional activation of PD-L1 by Sox2 contributes to the proliferation of hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Recurrent hepatocellular carcinoma cells with stem cell-like properties: possible targets for immunotherapy

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

Recognition and killing of cancer stem-like cell population in hepatocellular carcinoma cells by cytokine-induced killer cells via NKG2d-ligands recognition

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021

CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial.

1 reference

https://api.crossref.org/works/10.1038/S41416-020-0823-9

7 January 2021